New drug combo shrinks spleens in bone marrow cancer patients
NCT ID NCT02158858
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called pelabresib in people with certain blood cancers, including myelofibrosis and leukemia. In the first part, the drug was given alone to find the safest dose. In the second part, it was given with or without another drug (ruxolitinib) to see if it could shrink an enlarged spleen and reduce the need for blood transfusions. The trial involved 336 adults and has been completed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOU Maggiore della Carità
Novara, 28100, Italy
-
AOU S.Martino, IRCCS, IST-Istituto Nazionale Ricerca Sul Can
Genoa, Liguria, 16132, Italy
-
AZ Sint-Jan Burgge-Oostende AV- Campus Sint-Jan
Bruges, West-Vlaanderen, 8000, Belgium
-
Azienda Ospedaliero-Universitaria Careggi
Florence, 50134, Italy
-
Beatson West of Scotland Cancer Centre
Glasgow, G12 0YN, United Kingdom
-
Belfast City Hospital
Belfast, BT9 7AB, United Kingdom
-
CHRU de Lille - Hopital Claude Huriez
Toulouse, Haute-Garonne, 31059, France
-
CHRU de Lille - Hopital Claude Huriez - Maladies du Sang
Lille, Hauts-de-France, 59037, France
-
CHU - Hopital Saint Louis - Centre D'Investigations Clinique
Paris, 75010, France
-
Erasmus Universitair Medisch Centrum Rotterdam
Rotterdam, South Holland, 3015 AA, Netherlands
-
Froedtert & Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Guys and St Thomas' Hospital - Haematology
London, SE1 9RT, United Kingdom
-
ICAHN School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
IRCCS Policlinico San Matteo, Università degli studi di Pavi
Pavia, Lombardy, 27100, Italy
-
Institue of Hematology "L. and A. Seràgnoli"
Bologna, Emilia-Romagna, 40138, Italy
-
Institut Gustave Roussy
Villejuif, Île-de-France Region, 94805, France
-
Institut de cancérologie du Gard - Hematologie clinique
Nîmes, Gard, 30029, France
-
Instytut Hematologii i Transfuzjologii w Warszawie
Warsaw, Masovian Voivodeship, 02-776, Poland
-
Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
-
Juravinski Cancer Centre
Hamilton, Ontario, L8V 5C2, Canada
-
Maastricht University Medical Center
Maastricht, Limburg, 6229 HX, Netherlands
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Jacksonville
Jacksonville, Florida, 32224, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10021, United States
-
Northwestern University - Lurie Comprehensive Cancer Center
Chicago, Illinois, 60611, United States
-
Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda
Milan, Lombardy, 20122, Italy
-
Ospedale di Circolo, PO Varese, AO Ospedale di Circolo e Fon
Varese, Lombardy, 21100, Italy
-
Oxford University Hospitals
Headington, Oxford, OX3 7LE, United Kingdom
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
-
Servizio Sanitario Regionale Emilia-Romagna - Azienda Unita Sanitaria Locale (AUSL) di Rimini - Ospedale Infermi di Rimini
Rimini, Emilia-Romagna, 47923, Italy
-
St. Paul's Hospital
Vancouver, British Columbia, V6Z 2A5, Canada
-
The Christie Hospital
Manchester, M20 4BX, United Kingdom
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
UCLA Medical Center
Los Angeles, California, 90095, United States
-
UZ Leuven - Campus Gasthuisberg
Leuven, Viaams Braban, 3000, Belgium
-
University College London Hospital's NHS foundation Trust
London, NW1 2PG, United Kingdom
-
University Hospital of Wales
Cardiff, CF14 4XW, United Kingdom
-
University of Alberta Hospital
Edmonton, Alberta, T6G 2G3, Canada
-
University of Cambridge
Cambridge, CB2 0QQ, United Kingdom
-
University of Michigan Medical Center
Ann Arbor, Michigan, 48109, United States
-
Universitätsklinikum Bonn
Bonn, North Rhine-Westphalia, 53127, Germany
-
Universitätsklinikum Leipzig AöR
Leipzig, Saxony, 04103, Germany
-
Uniwersyteckie Centrum Kliniczne
Gdansk, Pomeranian Voivodeship, 80-952, Poland
-
VUmcResearch B.V.
Amsterdam, North Holland, 1081 HV, Netherlands
-
Washington University School of Medicne Neuromuscular Division Department of Neurology Research
St Louis, Missouri, 63110, United States
-
Weill Medical College and New York Presbyterian Hospital
New York, New York, 10065, United States
-
ZNA Stuyvenberg Antwerpen
Antwerp, 2060, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can discarded bone reveal the secrets to stronger bones?
- Can a Tumor's DNA guide better cancer care for kids?
- A simple screening program could transform cancer aftercare
- Can a Dual-Action pill tame bone marrow tumors?
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Can a new pill shrink the spleen in myelofibrosis?